{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:04:38Z","timestamp":1781762678997,"version":"3.54.5"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,4]]},"abstract":"<jats:p>Glioblastoma (GBM) is a common primary malignant brain tumor and the prognosis of these patients remains poor. Therefore, further understanding of cell cycle-related molecular mechanisms of GBM and identification of appropriate prognostic markers and therapeutic targets are key research imperatives. Based on RNA-seq expression datasets from The Cancer Genome Atlas database, prognosis-related biological processes in GBM were screened out. Gene Set Variation Analysis (GSVA), LASSO-COX, univariate and multivariate Cox regression analyses, Kaplan\u2013Meier survival analysis, and Pearson correlation analysis were performed for constructing a predictive prognostic model. A total of 58 cell cycle-related genes were identified by GSVA and analysis of differential expression between GBM and control samples. By univariate Cox and LASSO regression analyses, 8 genes were identified as prognostic biomarkers in GBM. A nomogram with superior performance to predict the survival of GBM patients was established regarding risk score, cancer status, recurrence type, and mRNAsi. This study revealed the prognostic value of cell cycle-related genes in GBM. In addition, we constructed a reliable model for predicting the prognosis of GBM patients. Our findings reinforce the relationship between cell cycle and GBM and may help improve the prognostic assessment of patients with GBM. Our predictive prognostic model, based on independent prognostic factors, enables tailored treatment strategies for GBM patients. It is particularly useful for subgroups with uncertain prognosis or treatment challenges.<\/jats:p>","DOI":"10.1097\/md.0000000000039205","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T21:18:11Z","timestamp":1728335891000},"page":"e39205","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Construction and validation of cell cycle-related prognostic genetic model for glioblastoma"],"prefix":"10.1097","volume":"103","author":[{"given":"Runpeng","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Pu\u2019er People\u2019s Hospital, Pu\u2019er, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Changzheng Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Bethune Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-4459","authenticated-orcid":false,"given":"Tian","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Fourth Military Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Bethune Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/neuonc\/nou283","article-title":"The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.","volume":"17","author":"de Robles","year":"2015","journal-title":"Neuro Oncol"},{"issue":"Suppl 5","key":"R2-20250503","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016.","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults.","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/neuonc\/nox012","article-title":"Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients.","volume":"19","author":"Cheng","year":"2017","journal-title":"Neuro Oncol"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/nan.12432","article-title":"WHO 2016 classification of gliomas.","volume":"44","author":"Wesseling","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches.","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: state of the art and future directions.","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"998236","DOI":"10.3389\/fimmu.2022.998236","article-title":"The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes.","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12539-015-0108-9","article-title":"Implying analytic measures for unravelling rheumatoid arthritis significant proteins through drug-target interaction.","volume":"8","author":"Singh","year":"2016","journal-title":"Interdiscip Sci"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1126\/science.1170411","article-title":"Computer science. Beyond the data deluge.","volume":"323","author":"Bell","year":"2009","journal-title":"Science"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12885-021-08591-0","article-title":"Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.","volume":"21","author":"Syafruddin","year":"2021","journal-title":"BMC Cancer"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"17445","DOI":"10.1002\/cam4.6316","article-title":"Identification of angiogenesis-related genes signature for predicting survival and its regulatory network in glioblastoma.","volume":"12","author":"Wan","year":"2023","journal-title":"Cancer Med"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"20406","DOI":"10.1038\/s41598-020-77259-9","article-title":"A novel methylation signature predicts radiotherapy sensitivity in glioma.","volume":"10","author":"Feng","year":"2020","journal-title":"Sci Rep"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/cns.13944","article-title":"A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma.","volume":"28","author":"Fan","year":"2022","journal-title":"CNS Neurosci Ther"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"714868","DOI":"10.3389\/fcell.2021.714868","article-title":"RECQ1 promotes stress resistance and DNA replication progression through PARP1 signaling pathway in glioblastoma.","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"112","DOI":"10.20892\/j.issn.2095-3941.2019.0164","article-title":"Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway.","volume":"17","author":"Lan","year":"2020","journal-title":"Cancer Biol Med"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"976007","DOI":"10.3389\/fgene.2022.976007","article-title":"Cuproptosis patterns and tumor immune infiltration characterization in colorectal cancer.","volume":"13","author":"Du","year":"2022","journal-title":"Front Genet"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"1056932","DOI":"10.3389\/fimmu.2022.1056932","article-title":"Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"e12988","DOI":"10.1111\/cpr.12988","article-title":"Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation.","volume":"54","author":"Wang","year":"2021","journal-title":"Cell Prolif"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12935-023-02950-6","article-title":"Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration.","volume":"23","author":"Yan","year":"2023","journal-title":"Cancer Cell Int"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1186\/s12885-023-11727-z","article-title":"Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.","volume":"23","author":"Dai","year":"2023","journal-title":"BMC Cancer"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1158\/1078-0432.CCR-10-0446","article-title":"Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2\/STAT3 signaling pathway.","volume":"16","author":"Weissenberger","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/nu13030950","article-title":"Anticancer mechanism of curcumin on human glioblastoma.","volume":"13","author":"Wong","year":"2021","journal-title":"Nutrients"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.semcancer.2022.11.006","article-title":"The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.","volume":"87","author":"Guo","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10495-016-1244-3","article-title":"Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers.","volume":"21","author":"Hu","year":"2016","journal-title":"Apoptosis"},{"issue":"Pt 2","key":"R31-20250503","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2022.09.005","article-title":"Unraveling tumor microenvironment of small-cell lung cancer: implications for immunotherapy.","volume":"86","author":"Li","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1758835919853449","DOI":"10.1177\/1758835919853449","article-title":"SOX11: friend or foe in tumor prevention and carcinogenesis?","volume":"11","author":"Yang","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"114285","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A nine-lncRNA signature predicts distant relapse-free survival of HER2-negative breast cancer patients receiving taxane and anthracycline-based neoadjuvant chemotherapy.","volume":"189","author":"Sun","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3389\/fcell.2020.00812","article-title":"MicroRNA: another pharmacological avenue for colorectal cancer?","volume":"8","author":"Wu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1073\/pnas.1320611111","article-title":"Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity.","volume":"112","author":"Meyer","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways.","volume":"455","year":"2008","journal-title":"Nature"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cgt.2013.46","article-title":"Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.","volume":"20","author":"Pezuk","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40659-022-00411-4","article-title":"Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.","volume":"56","author":"Zangouei","year":"2023","journal-title":"Biol Res"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12033-022-00465-5","article-title":"MiR-139-5p targeting CCNB1 modulates proliferation, migration, invasion and cell cycle in lung adenocarcinoma.","volume":"64","author":"Bao","year":"2022","journal-title":"Mol Biotechnol"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/15353702211049149","article-title":"CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle.","volume":"247","author":"Rong","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcp.26816","article-title":"Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.","volume":"234","author":"Zhang","year":"2018","journal-title":"J Cell Physiol"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1073274819855118","DOI":"10.1177\/1073274819855118","article-title":"Comprehensive analysis reveals a 4-gene signature in predicting response to temozolomide in low-grade glioma patients.","volume":"26","author":"Wang","year":"2019","journal-title":"Cancer Control"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"1533033821990368","DOI":"10.1177\/1533033821990368","article-title":"Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.","volume":"20","author":"Cui","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41598-022-08336-4","article-title":"Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer.","volume":"12","author":"Sun","year":"2022","journal-title":"Sci Rep"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"110216","DOI":"10.1016\/j.celrep.2021.110216","article-title":"ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization.","volume":"38","author":"Qin","year":"2022","journal-title":"Cell Rep"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.","volume":"18","author":"Lee","year":"2016","journal-title":"Neuro Oncol"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tranon.2017.11.007","article-title":"Serine\/threonine kinase CHEK1-dependent transcriptional regulation of RAD54L promotes proliferation and radio resistance in glioblastoma.","volume":"11","author":"Bai","year":"2018","journal-title":"Transl Oncol"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcb.30205","article-title":"The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.","volume":"123","author":"Kahl","year":"2022","journal-title":"J Cell Biochem"},{"key":"R49-20250503","first-page":"866","article-title":"Transcription factor ZEB1 regulates PLK1-mediated SKA3 phosphorylation to promote lung cancer cell proliferation, migration and cell cycle.","volume":"34","author":"Ning","year":"2023","journal-title":"Anticancer Drugs"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1111\/jcmm.13793","article-title":"PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells.","volume":"22","author":"Liu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2020.09.008","article-title":"Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.","volume":"533","author":"Wang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3171\/2022.6.JNS22319","article-title":"COL1A2 inhibition suppresses glioblastoma cell proliferation and invasion.","volume":"138","author":"Wang","year":"2023","journal-title":"J Neurosurg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:16:12Z","timestamp":1746317772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":52,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039205","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]}}}